Fintech Focus For July 23, 2021

Quote To Start The Day: "You know, everybody in the world will take a shower every morning but they don’t clean their brain."

Source: Peter Reznicek

One Big Thing In Fintech: Q2’21 was the largest funding quarter on record. Across 657 deals, global VC-backed fintech companies raised a record $30.8B, shattering last quarter’s funding record by 30%. This impressive funding growth was accompanied by a modest 2% deal growth quarter-over-quarter (QoQ) and a 29% increase year-over-year (YoY).

Source: CB Insights

Other Key Fintech Developments:

• Snapshots of fintech M&A themes.
• Thesis adds $21M Series A round.
• GlobalX has filed for a Bitcoin ETF.
• Visa bought Currencycloud fintech.
• Upgrade launches BTC credit card.
• Tiicker closed on a pre-seed round.
• Barclaycard tackles B2B payments.
• Symphony added Google for cloud.
• Currency.com joins an association.
• Magic raises $27M Series A round.
• Cambridge Savings eyeing fintech.
• HMBradley is shifting to invite-only.
• Core Scientific to offer on Nasdaq.
• Analyzing - the first bitcoin country.
• Spendesk nabs $118M for its tech.
• Prodigal adds $12M to streamline.

Watch Out For This: Professional traders with a retail background are few and far between.

This is due in part to the obstacles to success — a lack of direction and understanding, psychological alignment, among other things — so few manage to pass on their wisdom.

A mentor to many, Peter Reznicek, the co-founder and head trader at ShadowTrader, is a seasoned market veteran with whom Benzinga had the honor of speaking.

Reznicek details his early start, perspectives and tips for success, as well as his vision for the future.

Source: Benzinga

Interesting Reads:

• 5 criteria for digital transformations.
• Covid increasing in hot-spot areas.
• Pomp: Fix the money, fix the world.
• JPM’s Dimon is staying more years.

Market Moving Headline: A bipartisan group of senators is closing in on a $579 billion infrastructure deal after agreeing to pay for it in part by delaying a costly Trump-era Medicare regulation, but they don’t expect to announce details until at least Monday.

Source: Bloomberg